Latest filing published 18 Jan 2023 for Viridian Therapeutics, Inc.\DE, €141k.
Filing timeline
BuySaleInsider track record
Barrett Katz: trading record in brief
All filings by Barrett Katz on record concern Viridian Therapeutics, Inc.\DE. In total, 8 filings cover trades dated from 9 January 2023 to 17 January 2023.
On the market, this insider has only sold: 4 sales, €2.9M in total. Outside the open market, there are 4 option exercises.
The newest entry dates from 18 January 2023: an open-market sale of €854k, in Viridian Therapeutics, Inc.\DE. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Barrett Katz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,147 shares@ US$37.012.9% of flowCommon StockSEC:0000899243-23-002075:1
- 24,853 shares@ US$23.0310.9% of flowCommon StockSEC:0000899243-23-002075:2
- 24,853 shares@ US$37.2117.6% of flowCommon StockSEC:0000899243-23-002075:3
- 4,147 shares@ US$23.0324.4% of flowCommon StockSEC:0000899243-23-002075:0
- 12,623 shares@ US$33.048.1% of flowCommon StockSEC:0000899243-23-001626:1
- 47,377 shares@ US$23.0321.0% of flowCommon StockSEC:0000899243-23-001626:2
- 47,377 shares@ US$35.3032.1% of flowCommon StockSEC:0000899243-23-001626:3
- 12,623 shares@ US$23.0375.6% of flowCommon StockSEC:0000899243-23-001626:0
8 of 8 declarations
